Cheers @RBx, good idea. I'm not really worried about recent SP, it's just a good buying opportunity really.
But my top 3 would be similar to coolkiat:
1) Lupin-2 -- what's happening? Are NOX looking to partner with big pharma? Another investigator trial? Is it shelved for now?
2) Board composition: time to get some pharma connections on the board, I reckon.
3) CEP-2: why the delay? What was the ending to the grant fiasco?
Cheers @RBx, good idea. I'm not really worried about recent SP,...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $44.93K | 391.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 187852 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 124713 | 4 |
View Market Depth
| Last trade - 11.35am 17/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |